Understanding Triple Receptor Agonism
Triple receptor agonists represent the latest evolution in metabolic research, adding glucagon receptor activation to GLP-1 and GIP agonism. This approach combines appetite suppression, insulin sensitization, and energy expenditure enhancement in a single molecule.
The Three Receptor Systems
GLP-1 Receptor: Appetite suppression, glucose-dependent insulin secretion, gastric emptying delay, beta-cell preservation.
GIP Receptor: Insulin secretion potentiation, adipose tissue remodeling, bone metabolism regulation, nausea reduction.
Glucagon Receptor: Hepatic fat mobilization, thermogenesis increase, amino acid metabolism regulation, hepatic satiety signaling.
Advantages Over Dual Agonism
Triple agonists address a limitation of dual agonists: they primarily reduce energy intake without increasing expenditure. Glucagon receptor activation creates a state where the body both consumes fewer calories and burns more. Early data shows weight loss of 24-29%, exceeding dual agonist results.
Full Scale Peptides GLP-3R
Full Scale Peptides offers GLP-3R 10MG at 99%+ purity with third-party testing and COA. For laboratory research use only.